You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 17, November 5, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Complementary and Alternative Medicine
 •Statistics and Research Methods
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Integrity of Active Components of Botanical Products Used in Complementary and Alternative Medicine—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Stoney and colleagues about the importance of documenting the integrity and stability of biologically active components in botanical products. In our study, we used a supplier (Vital Nutrients Inc, Middletown, Connecticut) that provided independent confirmation of the certificate of analysis data provided by the botanical grower. The supplier also provided 2-year stability data of hypericin content from a previous sample of H perforatum. We believed that we would have similar stability in the product used in our study.

However, our research demonstrated that pretesting and posttesting of the product were not sufficient because we did not learn of the constituent degradation until the study was completed. It would have been better to do periodic monitoring of the botanical constituents and obtain a new batch of product for the study when the levels decreased. Therefore, we encourage botanical researchers to review the NCCAM policy . . . [Full Text of this Article]

Wendy Weber, ND, PhD, MPH
wendyw@bastyr.edu
Department of Naturopathic Medicine
Bastyr University
Kenmore, Washington

Jon McClellan, MD
Department of Psychiatry and Behavioral Sciences
University of Washington
Seattle



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Quality of Efficacy Research in Complementary and Alternative Medicine
Eugenia Chan
JAMA. 2008;299(22):2685-2686.
EXTRACT | FULL TEXT  

RELATED LETTERS

Integrity of Active Components of Botanical Products Used in Complementary and Alternative Medicine
Catherine M. Stoney, Paul Coates, and Josephine P. Briggs
JAMA. 2008;300(17):1995.
EXTRACT | FULL TEXT  

Integrity of Active Components of Botanical Products Used in Complementary and Alternative Medicine—Reply
Eugenia Chan
JAMA. 2008;300(17):1996.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.